HMX3
Homeobox protein HMX3
Also known as: HMX3_HUMAN, NKX5-1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- A6NHT5
- Gene
- HMX3
- Ensembl
- ENSG00000188620
- Chromosome
- 10
- Canonical length
- 357 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Centriolar satellite
OverviewNCBI Gene
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to act upstream of or within several processes, including embryo implantation; maternal process involved in female pregnancy; and neuromuscular process controlling balance. Predicted to be located in chromatin. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
357 residues, UniProt reviewed canonical sequence.
>A6NHT5|HMX3
1 MPEPGPDAAG TASAQPQPPP PPPPAPKESP FSIKNLLNGD HHRPPPKPQP PPRTLFAPAS
61 AAAAAAAAAA AAAKGALEGA AGFALSQVGD LAFPRFEIPA QRFALPAHYL ERSPAWWYPY
121 TLTPAGGHLP RPEASEKALL RDSSPASGTD RDSPEPLLKA DPDHKELDSK SPDEIILEES
181 DSEESKKEGE AAPGAAGASV GAAAATPGAE DWKKGAESPE KKPACRKKKT RTVFSRSQVF
241 QLESTFDMKR YLSSSERAGL AASLHLTETQ VKIWFQNRRN KWKRQLAAEL EAANLSHAAA
301 QRIVRVPILY HENSAAEGAA AAAAGAPVPV SQPLLTFPHP VYYSHPVVSS VPLLRPVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against HMX3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.67
- Highest tissue expression
- 4.5 nTPM
Expression across tissuesHPA
Tissue
- hypothalamus: 4.5 nTPM
- adipose tissue: 0.8 nTPM
- pituitary gland: 0.5 nTPM
- colon: 0.4 nTPM
- small intestine: 0.4 nTPM
- testis: 0.4 nTPM
Single-cell type
- tuft cells: 35 nCPM
- other brain neurons: 5.7 nCPM
- gastric progenitor cells: 2.6 nCPM
- lactotrophs: 1.7 nCPM
- pericytes: 1.1 nCPM
- vascular smooth muscle cells: 1.1 nCPM
Immune cell
- basophil: 1.5 nTPM
- neutrophil: 0.9 nTPM
- eosinophil: 0.4 nTPM
- naive B-cell: 0.4 nTPM
- NK-cell: 0.4 nTPM
- plasmacytoid DC: 0.4 nTPM
Brain region
- midbrain: 15 nTPM
- hypothalamus: 14 nTPM
- pons: 5.7 nTPM
- medulla oblongata: 3.4 nTPM
- thalamus: 2.4 nTPM
- amygdala: 1.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.37
- gnomAD pLI
- 0.92
- gnomAD missense Z
- 0.91
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- brain development
- cell differentiation
- embryo implantation
- inner ear morphogenesis
- maternal process involved in female pregnancy
- neuromuscular process controlling balance
- regulation of transcription by RNA polymerase II
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HMX3 as an antibody target. Whether an autoantibody or antibody against HMX3 could matter depends on whether native HMX3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HMX3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label HMX3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...